Thrombosis and hemorrhage in oncology patients

Hematology/Oncology Clinics of North America

Volumn 10, Issue 4, 1996, Pages 875-908

  Bick, R L ^a   Strauss, J F ^a   Frenkel, E P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BONE MARROW METASTASIS; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEMOSTASIS; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

EID: 0030015202     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70374-9     Document Type: Article

References (207)

1. T. Adams L. Shultz L. Goldberg Platelet function abnormalities in the myeloproliferative disorders Scand J Haematol 13 1974 215
2. Y.S. Ahn W.J. Harrington R.C. Seelman Vincristine therapy of idiopathic and secondary thrombocytopenias N Engl J Med 291 1974 376
3. M.A. Amundsen J.A. Spitell J.H. Thompson Hypercoagulability associated with malignant disease and with the postoperative state Ann Intern Med 58 1963 608
4. B. Astedt L. Svanberg I.M. Nilsson Cancer, FDP, and radiotherapy Br Med J 2 1972 47
5. R.M. Bennett Acute leukemia H. Rappaport Tutorial in Hematopathology 1980 Univ Chicago Press Chicago
6. S.W. Berkheiser The incidence of malignant cells in routine bone marrow examination Cancer 8 1955 958
7. M.M. Bern J.J. Lokich S.R. Wallach Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial Ann Intern Med 112 1990 423 428
8. 131I-fibrinogen Blood 35 1970 195
9. R.L. Bick Treatment of bleeding and thrombosis in the patient with cancer T. Nealon Management of the Patient with Cancer 1976 WB Saunders Philadelphia 48
10. R.L. Bick Disseminated intravascular coagulation and related syndromes. A review Am J Hematol 5 1978 265
11. R.L. Bick Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management Semin Thromb Hemost 5 1978 1
12. R.L. Bick Acquired circulating anticoagulants and defective hemostasis in malignant paraprotein disorders G. Murano R.L. Bick Basic Concepts of Hemostasis and Thrombosis 1980 CRC Press Boca Raton, FL 205
13. R.L. Bick Disseminated intravascular coagulation: A clinical/laboratory study of 48 patients D.A. Walz L.E. McCoy Contributions to Hemostasis. Ann N Y Acad Sci 370 1981 843
14. R.L. Bick The clinical significance of fibrinogen degradation products Semin Thromb Hemost 8 1982 302
15. R.L. Bick Syndromes associated with hyperfibrino(geno)lysis R.L. Bick Disseminated Intravascular Coagulation and Related Syndromes 1983 CRC Press Boca Raton, FL 105
16. R.L. Bick Basic mechanisms of hemostasis pertaining to DIC R.L. Bick Disseminated Intravascular Coagulation and Related Syndromes 1983 CRC Press Boca Raton, FL 1
17. R.L. Bick Circulating heparin activity in multiple myeloma Blood 64 1984 924
18. R.L. Bick Congenital and acquired coagulation protein defects associated with hemorrhage or thrombosis J. Powers Diagnostic Hematology: Clinical and Technical Aspects 1989 CV Mosby St. Louis 375
19. R.L. Bick Essential (Primary) Thrombocythemia. Hematology Check Sample # H-86-4. Hematology, vol 31, no 4 1989 Am Soc Clin Pathol Chicago
20. R.L. Bick Alterations of hemostasis associated with surgery, cardiopulmonary bypass surgery, and prosthetic devices O.D. Ratnoff C.D. Forbes Disorders of Hemostasis 1991 WB Saunders Philadelphia 382
21. R.L. Bick Qualitative (functional) platelet defects Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice 1992 ASCP Press Chicago 49
22. R.L. Bick Alterations of hemostasis in malignancy Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice 1992 ASCP Press Chicago 239
23. R.L. Bick Disseminated intravascular coagulation and related syndromes Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice 1992 ASCP Press Chicago 137
24. R.L. Bick Hypercoagulability and thrombosis Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice 1992 ASCP Press Chicago 261
25. R.L. Bick Alterations of hemostasis in malignancy R.L. Bick J.M. Bennett R.K. Brynes Hematology: Clinical and Laboratory Practice 1993 CV Mosby St. Louis 1583
26. R.L. Bick Disseminated intravascular coagulation: Objective criteria for diagnosis and management Med Clin North Am 78 1994 511
27. R.L. Bick Disseminated intravascular coagulation: Objective laboratory diagnostic criteria and guidelines for management Clin Lab Med 14 1994 729
28. R.L. Bick T. Adams Fibrinolytic activity in myeloproliferative disorders Clin Res 21 1973 264
29. R.L. Bick W.F. Baker Disseminated intravascular coagulation syndromes Hematol Pathol 6 1992 1
30. R.L. Bick L. Kunkel Disseminated intravascular coagulation Int J Hematol 55 1992 1
31. R.L. Bick S. Scates Disseminated intravascular coagulation Laboratory Medicine 23 1992 161
32. R.L. Bick W.L. Wilson Essential (hemorrhagic) thrombocythemia: A clinical and laboratory study of 14 patients Am J Clin Pathol 81 1984 799
33. R.L. Bick T. Adams W.R. Schmalhorst Bleeding times, platelet adhesion, and aspirin Am J Clin Pathol 65 1976 69
34. R.L. Bick L. Fekete G. Murano Daunomycin and fibrinolysis Thromb Res 9 1976 201
35. R.L. Bick L.F. Fekete W.L. Wilson Adriamycin and fibrinolysis Thromb Res 8 1976 467
36. R.L. Bick C.A. Klein L.F. Fekete Alterations of hemostasis associated with malignant paraprotein disorders Trans Am Soc Hematol 1976 163
37. R.L. Bick W.R. Schmalhorst E. Shanbrom Prothrombin complex concentrates: Use in controlling the hemorrhagic diathesis of chronic liver disease American Journal of Digestive Diseases 20 1975 741
38. D.R. Boggs M.M. Wintrobe C.E. Cartwright Acute leukemias: Analysis of 322 cases and review of the literature Medicine 41 1962 163
39. W.A. Boggust D.J. O'Brien R.A. O'Meara The coagulative factors of normal human and human cancer tissue Irish J Med Sci 6 1963 131
40. B.J. Boughton A. Simpson Plasma fibronectin in acute leukemia Br J Haematol 51 1982 487
41. E.G. Bovill W.B. Ershler E.A. Golden A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor Am J Clin Pathol 85 1986 115
42. P. Brakman J. Synder E.S. Henderson Blood coagulation and fibrinolysis in acute leukemia Br J Haematol 18 1970 135
43. C. Brassinne A. Coone M. Jijs Characterization of two direct fibrinogenolytic activities and one proteolytic inhibitor activity in the human prostate Thromb Res 8 1976 803
44. I. Brodsky J.F. Conroy The effects of chemotherapy on hemostasis Cancer Chemotherapy 2 1972 85
45. R.C. Brown D.C. Campbell J.H. Thompson Increased fibrinolysin with malignant disease Arch Intern Med 109 1962 129
46. J. Brook B.E. Konwaler Thrombotic thrombocytopenic purpura: Association with metastatic gastric carcinoma and a possible auto-immune disorder California Medicine 102 1965 222
47. U. Budde J.A. Dent S.D. Berkowitz Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome Blood 68 1986 1213
48. B. Bull M. Rubenberg J. Dacie Microangiopathic hemolytic anemia: Mechanisms of red-cell fragmentation Br J Haematol 14 1968 643
49. J.B. Bussel P.G. Steinherz D.R. Miller A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia Am J Hematol 16 1984 83
50. J. Caen Z. Sinakoz V. Sultan Les troubles du functionnement des plaquettes dans les leukemies myeloides chroniques Nouv Rev Fr Hematol 6 1966 719
51. J.M. Cardamone J. Edson J.K. McArthur Abnormalities of platelet function in the myeloproliferative disorders JAMA 221 1972 270
52. D.K. Cheung J.H. Raaf Selection of patients with malignant ascites for a peritoneovenous shunt Cancer 50 1982 1204
53. J.J. Choate D.F. Mosher Fibronectin concentration in plasma of patients with breast cancer, colon cancer, and acute leukemia Cancer 51 1983 1142
54. E.E. Cliffton C.E. Gross Fibrinolytic activity of human tumors as measured by the fibrinplate method Cancer 8 1955 1146
55. R.W. Coleman R.N. Rubin Disseminated intravascular coagulation due to malignancy Semin Oncol 17 1990 172
56. A.A. Cooperberg G.M.A. Neiman Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia Ann Intern Med 42 1955 706
57. D.M. Cowan M.J. Haut Platelet function in acute leukemia J Lab Clin Med 79 1972 893
58. R.B. Davis A. Theologides B.J. Kennedy Comparative studies of blood coagulation and platelet aggregation in patients with cancer and non-malignant disease Ann Intern, Med 71 1969 67
59. P. Didisheim E.J.W. Bowie C.A. Owen Intravascular coagulation fibrinolysis (ICF) syndrome and malignancy: Historical review and report of two cases with metastatic carcinoid and with acute myelomonocytic leukemia Thrombosis et Diathesis Haemorrhagica 36 1969 215
60. J. Diebold T.P. Camilieri J. Delarue Les lesions hepatiques au cours des leucoses. Etude histopathologique Ann Anat Pathol (Paris) 14 1969 41
61. J.T. Douglas G.D.O. Lowe C.D. Forbes Beta-thromboglobulin and platelet counts: Effect of malignancy, infection, age, and obesity Thromb Res 25 1982 459
62. P.E. Drakos A. Nagler R. Or Low molecular weight heparin for Hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation Cancer 70 1992 1895 1898
63. E.A. Edwards Migrating thrombophlebitis associated with carcinoma N Engl J Med 240 1949 1031
64. R.E. Enck C.N. Rios Tamoxifen treatment of metastatic breast cancer and antithrombin III levels Cancer 53 1984 2607
65. H.E. Evans I.J. Wolman Problems in the diagnosis and management of acute leukemia in childhood Clin Pediatr 10 1971 571
66. F.S. Ey S.H. Goodnight Bleeding disorders in cancer Semin Oncol 17 1990 187
67. F. Fabris A. Casonato M.G. Del Ben Abnormalities of von Willebrand factor in myeloproliferative disease: A relationship with bleeding diathesis Br J Haematol 63 1986 75
68. M.J. Farbstein K.G. Blume Acute leukemia K.G. Blume L.D. Petz Clinical Bone Marrow Transplantation 1983 Churchill Liningstone New York 271
69. J. Fareed J.M. Walenga R.L. Bick Impact of automation on the quantitation of low molecular weight markers of hemostatic defects Semin Thromb Hemost 9 1983 355
70. S.E. Feffer L.S. Carmosino R.L. Fox Acquired Protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fiuorouracil Cancer 63 1989 1303
71. D.I. Feinstein Treatment of disseminated intravascular coagulation Semin Thromb Hemost 14 1988 351
72. C. Fisch A.W. Jones W.D. Gambill Acute thrombophlebitis associated with carcinoma of the stomach Gastroenterology 18 1951 290
73. S. Fisher B. Ramot B. Kreisler Fibrinolysis in acute leukemia Isr Med J 19 1960 195
74. J. Folkman Tumor angiogenesis: Therapeutic implications N Engl J Med 285 1971 1182
75. K.A. Foon R.E. Champlin R.P. Gale Acute myelogenous leukemia and the myelodys-plastic syndromes C.M. Haskell Cancer Treatment 1990 WB Saunders Philadelphia 589
76. P.G. Frick Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer Acta Haematol (Basel) 16 1956 11
77. I.A. Friedman S.O. Schwartz S.L. Leifhold Platelet function defects with bleeding Arch Intern Med 113 1964 177
78. M.J. Galloway M.J. Mackie B.A. McVerry Combinations of increased thrombin, plasmin, and non-specific protease activity in patients with acute leukemia Haemostasis 13 1983 322
79. G.F. Gardner Platelet transfusion M.G. Baldin S. Elbe Platelets: Production, Function and Storage 1974 Grune and Stratton New York 393
80. A. Girolami E.E. Cliffton Fibrinolytic and proteolytic activity in acute and chronic leukemia Am J Med Sci 51 1966 638
81. J.A. Glaspy Hemostatic defects in multiple myeloma and related disorders Hematol Oncol Clin North Am 6 1992 1301
82. G.H. Goldsmith Hemostatic disorders associated with malignancy O.D. Ratnoff C.D. Forbes Disorders of Hemostasis 1991 WB Saunders Philadelphia 352
83. S.H. Goodnight Bleeding and intravascular clotting in malignancy: A review Ann NY Acad Sci 230 1974 271
84. C.T. Goodnough H. Saito A. Mann Increased incidence of thromboembolism in Stage IV breast cancer patients treated with a five drug chemotherapy regimen Cancer 54 1984 1264
85. S.G. Gordon Cancer cell procoagulants and their implications Hematol Oncol Clin North Am 6 1992 1359
86. I. Gore Thrombosis and pancreatic cancer Am J Pathol 29 1953 1093
87. J. Goudemand B. Samor C. Caron Acquired Type II von Willebrand's disease: Demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment Br J Haematol 68 1988 227
88. J.R. Gould H.W. Carloss W.L. Skinner Groshong catheter-associated subclavian venous thrombosis Am J Med 95 1993 419 423
89. H.R. Gralnick H.K. Tan Acute promyelocytic leukemia. A model for understanding the role of the malignant cells in hemostasis Hum Pathol 5 1974 661
90. H.R. Gralnick J. Bagley E. Abrell Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia Am J Med 52 1974 167
91. W.D. Haire J.B. Atkinson L.C. Stephens G.D. Kotulak Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial Thromb Haemost 72 1994 543 547
92. W.D. Haire R.P. Lieberman G.B. Lund Obstructed central venous catheter: Restoring function with a 12-hour infusion of low-dose urokinase Cancer 66 1990 2279 2285
93. T. Han L. Stutzman E. Cohen Effect of platelet transfusion on hemorrhage in patients with acute leukemia Cancer 19 1966 1937
94. H.H. Hansen F.M. Muggia O.S. Selawry Bone marrow examination in 100 consecutive patients with bronchogenic carcinoma Lancet 1 1971 443
95. L.A. Harker C.A. Finch Thrombokinetics in man J Clin Invest 48 1969 963
96. D.C. Harmon Z. Demirjian L. Ellman Disseminated intravascular coagulation with the peritoneovenous shunt Ann Intern Med 90 1979 714
97. K. Hayano H. Fukui Y. Otsuka Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy Nippon Jinzo Gakkai Shi 30 1988 835
98. E.S. Henderson Acute myelogenous leukemia W.J. Williams E. Beutler A.J. Erslev R.W. Rundies Hematology 1977 McGraw-Hill New York 830
99. E.M. Hersh G.P. Bodey B.A. Nies Causes of death in acute leukemia: A ten year study of 414 patients from 1954–1963 JAMA 193 1965 105
100. D.W. Heustis J.R. Bove S. Busch Practical Blood Transfusion 1969 Little, Brown Boston
101. J.M. Holt E.G. Gordon-Smith Retinal abnormalities in diseases of the blood Br J Ophthalmol 53 1969 145
102. M.H. Horellou E. Baumelou N. Sitbon Four cases of acquired Willebrand Factor deficiency associated with monoclonal dysglobulinemia Ann Med Interne (Paris) 134 1983 707
103. M.K. Home 3rd D.J. May H.R. Alexander Venographic surveillance of tunneled venous access devices in adult oncology patients Ann Surg Oncol 2 1995 174 178
104. K. Huth H. Loftier U. Lechlemayer Verbrauchskoagulopathie bei unreifzelligen keukosen Verh Dtsch Ges Inn Med 74 1968 147
105. E. Ikkala Transfusion therapy in congenital deficiencies of plasma factor XIII Ann NY Acad Sci 202 1972 200
106. I. Innerfield A. Anrist J.W. Benjamin Plasma antithrombin patterns in disturbances of the pancreas Gastroenterology 19 1951 843
107. S. Jain A.E. Seymour Mitomycin C associated hemolytic uremic syndrome Pathology 19 1987 58
108. K. Jamshidi W.R. Swaim Bone marrow biopsy with unaltered architecture: A new biopsy device J Lab Clin Med 77 1971 335
109. M.R. Jerman R.B. Fick Nonbacterial thrombotic endocarditis associated with bone marrow transplantation Chest 90 1986 919
110. U. Jonsson R.W. Rundies Tumor metastases in bone marrow Blood 6 1951 16
111. S. Kirchmayer I. Stalowa B. Biernacka Measurements of proteolytic activity of leukoblasts—a new diagnostic method Pol Arch Med Wewn 44 1970 365
112. M.S. Khoory M.E. Nesheim E.J.W. Bowie Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder J Clin Invest 65 1980 666
113. P. Klener P. Kubisz J. Suranova Influence of cytotoxic drugs on platelet functions and coagulation Thromb Hemost 37 1977 53
114. S. Kumar B. Monorama Pre-leukemic acute myelogenous leukemia Acta Haematol 3 1970 21
115. L.A. Kunkel Acquired circulating anticoagulants Hematol Oncol Clin North Am 6 1992 1359
116. K. Kuramoto S. Matsushita H. Yamanouchi Nonbacterial thrombotic endocarditis as a cause of cerebral and myocardial infarction Jpn Circ J 48 1984 1000
117. B.I. Kuznik E.L. Kuzmiehco G.P. Alnikov On the role of leukocytes in the process of blood coagulation in chronic lymphocytic leukemia Probl Gematol Pereliv Krovi 14 1969 3
118. H.C. Kwaan R. Lo A.J.S. McFadzean Antifibrinolytic activity in primary carcinoma of the liver Clin Sci 18 1959 251
119. P.F. Lanier Sternal marrow in patients with metastatic cancer Arch Intern Med 84 1949 891
120. J. Lazarachick A.A. Pappas J. Kizer Acquired von Willebrand's syndrome due to an inhibitor specific for von Willebrand Factor antigens Am J Hematol 21 1986 305
121. R.A. Leavy S.B. Kahn I. Brodsky Disseminated intravascular coagulation: A complication of chemotherapy in acute promyelocytic leukemia Cancer 26 1970 142
122. J.M. Leiby H. Purcell J.J. DeMaria Pulmonary embolism as a result of Hickman catheter-related thrombosis Am J Med 86 1989 228 231
123. R.G. Lerner J.C. Nelson P. Corines L.R.M. del Guercio Disseminated intravascular coagulation: Complication of LeVeen peritoneovenous shunts JAMA 240 1984 2064
124. J. Levin C.L. Conley Thrombocytosis associated with malignant disease Arch Intern Med 114 1964 487
125. M.N. Levin M. Gent J. Hirsh The thrombogenic effect of anticancer drug therapy in women with Stage II breast cancer N Engl J Med 318 1988 404
126. J. Lisiewicz Chronic granulocytic leukemia Hemorrhage in Leukemias 1976 Polish Med Publ Warsaw 82
127. J. Lisiewicz Chronic lymphocytic leukemia Hemorrhage in Leukemias 1976 Polish Med Publ Warsaw 104
128. J. Lisiewicz Mechanisms of hemorrhage in leukemias Semin Thromb Hemost 4 1978 241
129. J. Lisiewicz Disseminated intravascular coagulation in acute leukemia Semin Thromb Hemost 14 1988 339
130. J. Lisiewicz P. Moszcynski Disturbances of hemostasis in patients with various leukemia types in the light of results of basic tests of blood coagulation and fibrinolysis Przegl Lek 29 1972 389
131. J. Lisiewicz P. Moszcynski Leukocytosis and fibrinolytic activity of the blood in the leukemic patients Rev Med Interne 1 1975 37
132. R.B. Livingston S.K. Carter Single Agents in Cancer Chemo-therapy 1970 Plenum Press New York
133. G. Luzzatto A.I. Schaffer The prethrombotic state in cancer Semin Oncol 17 1990 147
134. A. Marguliusa D.P. Jackson O.D. Ratnoff Circulating anticoagulants: A study of 40 cases and review of the literature Medicine (Baltimore) 40 1961 145
135. A.M. Marmont E.E. Damasio E. Gori Vinblastine sulfate in idiopathic thrombocytopenic purpura Lancet 2 1971 94
136. J.H. Marymount S. Gross Patterns of metastatic cancer in the spleen Am J Clin Pathol 40 1963 58
137. M. Matsuoka Y. Onishi Pathologic cells as procoagulant substances of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia Thromb Res 8 1976 263
138. D.J. Mayo D.C. Pearson Chemotherapy extravasation: A consequence of fibrin sheath formation around vascular access devices Oncol Nurs Forum 22 1995 675 680
139. J.T. McCarthy B.A. Staats Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome Chest 89 1986 608
140. B.F. Mertins L.F. Green E.J.W. Bowie Fibrinolytic split products and ethanol gelation test in pre-operative evaluation of patients with prostatic disease Mayo Clin Proc 49 1974 642
141. S. Meschengieser A. Blanco N. Maugeri Platelet and intraplatelet von Willebrand factor antigen and fibrinogen in myelodysplastic syndromes Thromb Res 46 1987 601
142. J.B. Miale Laboratory Medicine Hematology 1972 CV Mosby St. Louis 53
143. S.P. Miller J. Sanchez-Avalos T. Stefanski Coagulation disorders in cancer. I. Clinical and laboratory studies Cancer 20 1967 1452
144. A. Milne S. Talbot D. Bevan Thrombosis during cytotoxic chemotherapy Br Med J 297 1988 624
145. K. Miyagawa Y. Kawakita Ultrastructure of blood platelets in various hematologic disorders Acta Haematol (Japan) 32 1969 64
146. H. Mohri Acquired von Willebrand's disease and storage pool disease in chronic myelocytic leukemia Am J Hematol 22 1986 391
147. H. Mohri T. Noguchi F. Kodama Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor Am J Clin Pathol 87 1987 663
148. M. Monreal A. Raventos R. Lerma Pulmonary embolism in patients with upper extremity DVT associated with venous central lines—a prospective study Thromb Haemost 72 1994 548 550
149. R.W. Monto R.W. Talley M.J. Caldwell Observation on the mechanisms of hemorrhagic toxicity in mithramycin therapy Cancer Res 29 1969 697
150. S.E. Moolton L. Vroman G.M.S. Broman Role of blood platelets in thromboembolism Arch Intern Med 84 1949 667
151. M. Morrison An analysis of the blood picture in 100 cases of malignancy J Lab Clin Med 17 1932 1071
152. P. Moszczynski J. Lisiewicz Early symptoms of acute and chronic leukemias in 300 patients Med Wiejska 8 1973 249
153. P. Moszczynski J. Lisiewicz The liver function in leukemic patients in the light of enzymatic studies Pol Tyg Lek 29 1974 1925
154. R.M. Nalbandian R.L. Henry R.L. Bick Thrombotic thrombocytopenic purpura Semin Thromb Hemost 5 1979 216
155. R.E. Olson Vitamin K-induced prothrombin formation antagonism by actinomycin-D Science 145 1964 926
156. J.B. Omar H.S. Saxena H.S. Mitel Fibrinolytic activity in malignant diseases J Assoc Physicians India 19 1971 293
157. R.A.Q. O'Meara Coagulation properties of cancers Ir J Med Sci 394 1958 474
158. C.A. Owen H.C. Oels E.J.W. Bowie Chronic intravascular coagulation syndrome Thrombosis et Diathesis Haemorrhagica 36 1969 197
159. R.N. Palmer M.E. Rick P.D. Rick Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder N Engl J Med 310 1984 1696
160. W.P. Patterson Q.S. Ringenberg The pathophysiology of thrombosis in cancer Semin Oncol 17 1990 140
161. W.P. Patterson C.W. Caldwell D.C. Doll Hyperviscosity syndromes and coagulopathies Semin Oncol 17 1990 210
162. S. Perry Coagulation defects in leukemia J Lab Clin Med 50 1957 229
163. L.L. Phillips V. Skrodelis C.A. Furey The fibrinolytic enzyme system in prostatic cancer Cancer 12 1959 721
164. G.F. Pineo F. Regorczi M.W.C. Hatton The activation of coagulation by extracts of mucin: A possible pathway of intravascular coagulation accompanying adenocarcinomas J Lab Clin Med 82 1973 255
165. G.F. Pineo M.C. Brain A.S. Gallus Tumors, mucus production, and hypercoagulability Ann NY Acad Sci 230 1974 262
166. A.V. Pisciotta E.J. Schulz Fibrinolytic purpura in acute leukemia Am J Med 19 1955 824
167. A. Polliack Acute promyelocytic leukemia with disseminated intravascular coagulation Am J Clin Pathol 56 1971 155
168. R. Qazi E.D. Savlov Peritoneovenous shunt for palliation of malignant ascites Cancer 49 1982 600
169. I.I. Raad M. Luna S.A. Khalil The relationship between the thrombotic and infectious complications of central venous catheters JAMA 271 1994 1014 1016
170. S.I. Rapaport C.G. Chapman Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma Am J Med 27 1959 144
171. F.R. Rickles R.L. Edwards C. Barb Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth Cancer 51 1983 301
172. P.J. Rosen Bleeding problems in the cancer patient Hematol Oncot Clin North Am 6 1992 1315
173. F. Rosner J.V. Dobbs D.N. Ritz Disturbances of hemostasis in acute myeloblastic leukemia Acta Haematol 43 1970 65
174. M.H. Rosove G.E. Schwartz Hematologic complications of cancer and its treatment C.M. Haskell Cancer Treatment 1990 WB Saunders Philadelphia 850
175. P. Rubin G.W. Casareh Clinical Radiation Pathology 1968 WB Saunders Philadelphia 778
176. R.N. Rubin Local installation of small doses of streptokinase for treatment of thrombotic occlusions of long-term access catheters J Clin Oncol 1 1983 572 573
177. J. Sanchez-Avalos B.C.F. Soong S.P. Miller Coagulation disorders in cancer. II. Multiple myeloma Cancer 23 1969 1388
178. S.M. Scates Diagnosis and treatment of cancer-related thrombosis Hematol Oncol Clin North Am 6 1992 1329
179. P.J. Schwab J.L. Fahey Treatment of Waldenstrom's macroglobulinemia by plasmapheresis N Engl J Med 263 1960 574
180. E.J. Seifter W.R. Bell Platelet disorders Coagulation Disorders in the Cancer Patient 1984 Futura Publishing Mount Kisco, NY 15
181. E.L. Seigel A.C. Jew R. Delcore Thrombolytic therapy for catheter-related thrombosis Am J Surg 166 1993 716 718 discussion: 718–719
182. R. Sheldon D. Slaughter A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma Cancer 58 1986 1428
183. H.M. Shulman A.M. Gown D.J. Nugent Hepatic veno-occlusive disease after bone marrow transplantation Am J Pathol 127 1987 549
184. N.M. Shustrova On the permeability of vascular walls in some disorders of the blood system 1965 Doctoral dissertation, Alma-Ata
185. L.I.E. Silberstein J. Abrahm S.J. Shattil The efficacy of intensive plasma exchange in acquired von Willebrand's disease Transfusion 27 1987 234
186. S.J. Stickter L.A. Harker Hemostasis in malignancy Ann NY Acad Sci 230 1974 252
187. B.C.F. Soong S.P. Miller Coagulation disorders in cancer: Fibrinolysis and inhibitors Cancer 25 1970 867
188. E.F. Sproul Carcinoma and venous thrombosis: The frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis Am J Cancer 34 1938 566
189. S.F. Stein J.T. Fulenwider J.D. Ansley Accelerated fibrinogen and platelet destruction after peritoneovenous shunting Arch Intern Med 141 1981 1149
190. K.M. Sullivan Graft-versus-host disease K.G. Blume L.D. Petz Clinical Bone Marrow Transplantation 1983 Churchill Liningstone New York 91
191. Sultan C, Gounault M, Varet B: Relationship between the cell morphology of acute myeloblastic leukemia and occurence of a syndrome of disseminated intravascular coagulation [abstract 603]. XIV Int Congr Hematol, Sao Paulo, 1972
192. Y. Sultan J. Delobel J. Caen Anomalies de l'hemostase primaire au cours des leucemies myeloides chroniques et des autres syndromes myeloproliferatifs Actual Hematol (Paris) 3 1969 95
193. J. Sznajd J. Naskalski J. Liciewicz Antiheparin activity of myeloperoxidase and ribonuclease of chronic granulocytic leukemia leukocytes Pol Arch Med Wewn 42 1969 207
194. H. Takahashi R. Nagayama Y. Tanabe DDAVP in acquired von Willebrand syndrome associated with multiple myeloma Am J Hematol 22 1986 421
195. J. Tatarsky Z. Sinakos M.J. Larrieu Leukocytes et fibrinolyse. II. Etudes des leukocytes pathologiques Nouv Rev Fr Hematol 7 1967 95
196. W. Tatewaki H. Takahashi K. Wada Plasma von Willebrand factor proteolysis in patients with chronic myeloproliferative disorders: No possability of ex vivo degradation by calcium-dependent proteolysis Thromb Res 56 1989 191
197. A. Trousseau Phlegmasia alba dolens Clinique Medicale de L'Hotel Dieu de Paris 3 ed 2 1865 Balliere Paris
198. L.E. Trunova The pathogenesis of the hemorrhagic system in acute leukemia Vrach Delo 11 1965 41
199. J. Valkov Histologic studies of extramedullary hemopoiesis in leukemias and its relationship to the blood vessels Med Fizkult 42 1963 35
200. J. van Creveld J.A. Mochtar Fibrinolysis in acute leukemia Pediatr Ann 194 1960 65
201. G.J. Ventura J.P. Hester D.O. Dixon Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia Hematol Pathol 3 1989 23
202. H. Wado T. Nagano M. Tomeoku Coagulant and fibrinolytic activities in the leukemic cell lysates Thromb Res 30 1982 315
203. J.M. Walenga J. Fareed G. Mariani Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B-beta 15-42 sequence Semin Thromb Hemost 10 1984 252
204. A. Wehmeier R.E. Scharf S. Fricke Bleeding and thrombosis in chronic myeloproliferative disorders: Relation of platelet disorders to clinical aspects of the disease Haemostasis 19 1989 251
205. R.B. Weiss D.C. Tormey J.F. Holland Venous thrombosis during multimodal treatment of primary breast carcinoma Cancer Treat Rep 65 1981 677
206. M.L. Yip S. Lee H.J. Sacks Nonspecificity of the protamine sulfate test for intravascular coagulation Am J Clin Pathol 57 1972 487
207. Y. Yodo T. Abe Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease Thromb Haemost 46 1981 706